NR 565 MIDTERM
STUDY GUIDE
Advanced Pharmacology | NP
Weeks 1-4 Complete Review
Course: NR 565 – Advanced Pharmacology
Program: Master's Degree – Nurse Practitioner (NP)
Institution: Chamberlain University
Year: 2026
Author: Graduate Nursing Student
� WEEK 1 – Foundations
✅Prescriptive Authority • APRN Practice
✅Pharmacokinetics • Pharmacodynamics
✅Boxed Warnings • BEERS Criteria
✅Special Populations (Peds, Geriatrics, Pregnancy)
� WEEK 2 – Cardiovascular/Renal
✅Diuretics (Loop, Thiazide, K+-Sparing)
✅ACE Inhibitors • ARBs • RAAS System
✅Calcium Channel Blockers • Digoxin
✅Beta-Blockers • Amiodarone
� WEEK 3 – Lipids & Angina
✅Statins • Ezetimibe • PCSK9 Inhibitors
✅Heparin • Warfarin
✅Angina (Stable, Variant, Unstable)
✅Nitroglycerin • Ranolazine
� WEEK 4 – Pain, Gout, Osteoporosis
✅Opioids (Schedules I-V) • Naloxone • PDMP
✅NSAIDs • COX-2 Inhibitors
✅Gout (Colchicine, Allopurinol)
✅Osteoporosis (Bisphosphonates, Raloxifene)
✅DMARDs (Methotrexate, Hydroxychloroquine)
✅CYP450 System • Inducers vs Inhibitors
✅Correct Answers & Detailed Rationales
✅Perfect for NR 565 Midterm Exam Prep
, NR 565 Midterm Study Guide – Advanced
Pharmacology | Weeks 1-4 | Questions &
Answers with Rationales | Chamberlain
University
Week 1
Chapter 1
• State laws impact on prescriptive authority
o APRNs can prescribe schedule II-V
• Full Practice Authority
o NPs can conduct client evaluations, diagnose, order and interpret
diagnostic tests and initiate and manage treatments
▪ Prescribing medications and controlled substances.
o This level of practice occurs under the state board of nursing’s exclusive
licensure and is the preferred model by leading national nursing and
medical organizations
• Reduced practice
o NPs are limited in at least one element of practice. The state requires a
formal collaborative agreement with an outside health discipline for the
nurse practitioner to provide patient care
• Restricted practice
o NPs are limited in at least one element of practice by requiring
supervision, delegation, or team management by an outside health
discipline for the nurse practitioner to provide patient care
• Role: Prescriptive Authority
o Nurse practitioner scope of practice is determined by state practice and
licensure laws
o Limited authority creates problems for the patient. The patient may not be
able to get the care that they need
o Regulates prescribing rights beyond medications and controlled
substances
▪ Also, therapeutic devices and services and are outlined in state
practice laws and regulations and include DME and medical
services like PT/OT/HHC.
• Key responsibilities of prescribing
o Be prudent and deliberate in your decision-making process
o Have a documented provider-patient relationship with the person for
whom you are prescribing
o Do not prescribe medications for family or friends or for yourself
o Document a thorough history and physical examination in your records
o Include any discussions you have with the patient regarding risk factors,
side effects or therapy options
, o Have a documented plan regarding drug monitoring or titration, if
applicable
Chapter 3:
• Generic vs Brand Name: Value of Knowing
o Generic drugs are chemically identical to their brand-name counterparts
but are typically less expensive. Must meet same standards for quality,
safety, and efficacy.
• Duration of Therapy
o Length of time a medication should be taken to effectively treat a
condition. It is important to follow prescribed durations to ensure that the
medication works as intended and to prevent issues such as drug
resistance or relapse of the condition
• Role of Formularies
o List of medications that are preferred and covered by a particular health
insurance plan or healthcare system. Designed to guide prescribing
practices by promoting cost-effective treatments while ensuring that
effective and safe medications are available.
• Blood Flow Impact on Absorption
o Medications can affect blood flow in various ways, such as by dilating or
constricting blood vessels, impacting blood pressure, or influencing blood
clotting.
Chapter 4:
• Excretion Process
o Involves the removal of drugs and their metabolites from the body
• Metabolism Process
o Body chemically alters drugs for therapeutic use and forms them into
components that can be more easily excreted
• Distribution Process
o Once in the bloodstream, a drug must be distributed to sites of action
throughout the body via the vascular system
• Passage Across Membranes
• Absorption Process
o Process by which a drug moves from its administration site into the blood
stream
• Rate of Dissolution
• Surface Area and Absorption
• Multiple drugs on metabolic pathways
• Therapeutic Consequences
• Impact of drug selectivity on side effects
, o How specifically a medication targets its intended receptor or enzyme.
Highly selective drugs generally produce fewer side effects because they
interact with fewer non-target receptors or enzymes
• Receptors and Selectivity of Drug Action
o Specific proteins on or within cells that drugs bind to produce their effects.
Selectivity of a drug is determined by how well it binds to its intended
receptor compared to other receptors.
• Noncompetitive Antagonists
o Bind to a receptor at a different site than the agonist (the substance that
normally activates the receptor), altering the receptors shape and
preventing the agonist from producing its effect. They inhibit the receptors
activity even in the presence of the agonist
• Noncompetitive Antagonists Action
o Binding to a receptor and changing its conformation, which blocks or
diminishes the receptors response to agonists. This means that even if the
agonist is present, the receptor will not be activated, leading to a reduction
in the intended physiological response.
• Identifying Adverse Drug Reactions
o ARDS – involves monitoring and recognizing unwanted or harmful effects
that occur in response to a medication. This includes looking for
symptoms or signs that deviate from the expected therapeutic effects,
requiring careful observation and reporting to ensure patient safety
Chapter 5:
• FDA & QT Interval Drugs
o The QT interval is a measure on an ECG that represents the time it takes
for the hearts electrical system to reset after each heartbeat. Some drugs
can prolong the QT interval, potentially leading to serious heart
arrhythmias
o The FDA monitors these drugs closely and provides warnings or
recommendations to minimize the risk of complications.
• Boxed Warnings
o Most serious warnings required by the FDA. Highlighted on the drugs label
to alert HCP and patients to the significant risks of severe or life-
threatening adverse effects associated with the medication
• Boxed Warnings: Drug Examples
o Antidepressants: boxed warnings for increased risk of suicidal thoughts in
children, adolescents, and young adults
o Antipsychotics: boxed warnings for increased risk of death in elderly
patients with dementia-related psychosis
o Opioids: boxed warnings for risk of addiction, abuse, and misuse that can
lead to overdose and death
STUDY GUIDE
Advanced Pharmacology | NP
Weeks 1-4 Complete Review
Course: NR 565 – Advanced Pharmacology
Program: Master's Degree – Nurse Practitioner (NP)
Institution: Chamberlain University
Year: 2026
Author: Graduate Nursing Student
� WEEK 1 – Foundations
✅Prescriptive Authority • APRN Practice
✅Pharmacokinetics • Pharmacodynamics
✅Boxed Warnings • BEERS Criteria
✅Special Populations (Peds, Geriatrics, Pregnancy)
� WEEK 2 – Cardiovascular/Renal
✅Diuretics (Loop, Thiazide, K+-Sparing)
✅ACE Inhibitors • ARBs • RAAS System
✅Calcium Channel Blockers • Digoxin
✅Beta-Blockers • Amiodarone
� WEEK 3 – Lipids & Angina
✅Statins • Ezetimibe • PCSK9 Inhibitors
✅Heparin • Warfarin
✅Angina (Stable, Variant, Unstable)
✅Nitroglycerin • Ranolazine
� WEEK 4 – Pain, Gout, Osteoporosis
✅Opioids (Schedules I-V) • Naloxone • PDMP
✅NSAIDs • COX-2 Inhibitors
✅Gout (Colchicine, Allopurinol)
✅Osteoporosis (Bisphosphonates, Raloxifene)
✅DMARDs (Methotrexate, Hydroxychloroquine)
✅CYP450 System • Inducers vs Inhibitors
✅Correct Answers & Detailed Rationales
✅Perfect for NR 565 Midterm Exam Prep
, NR 565 Midterm Study Guide – Advanced
Pharmacology | Weeks 1-4 | Questions &
Answers with Rationales | Chamberlain
University
Week 1
Chapter 1
• State laws impact on prescriptive authority
o APRNs can prescribe schedule II-V
• Full Practice Authority
o NPs can conduct client evaluations, diagnose, order and interpret
diagnostic tests and initiate and manage treatments
▪ Prescribing medications and controlled substances.
o This level of practice occurs under the state board of nursing’s exclusive
licensure and is the preferred model by leading national nursing and
medical organizations
• Reduced practice
o NPs are limited in at least one element of practice. The state requires a
formal collaborative agreement with an outside health discipline for the
nurse practitioner to provide patient care
• Restricted practice
o NPs are limited in at least one element of practice by requiring
supervision, delegation, or team management by an outside health
discipline for the nurse practitioner to provide patient care
• Role: Prescriptive Authority
o Nurse practitioner scope of practice is determined by state practice and
licensure laws
o Limited authority creates problems for the patient. The patient may not be
able to get the care that they need
o Regulates prescribing rights beyond medications and controlled
substances
▪ Also, therapeutic devices and services and are outlined in state
practice laws and regulations and include DME and medical
services like PT/OT/HHC.
• Key responsibilities of prescribing
o Be prudent and deliberate in your decision-making process
o Have a documented provider-patient relationship with the person for
whom you are prescribing
o Do not prescribe medications for family or friends or for yourself
o Document a thorough history and physical examination in your records
o Include any discussions you have with the patient regarding risk factors,
side effects or therapy options
, o Have a documented plan regarding drug monitoring or titration, if
applicable
Chapter 3:
• Generic vs Brand Name: Value of Knowing
o Generic drugs are chemically identical to their brand-name counterparts
but are typically less expensive. Must meet same standards for quality,
safety, and efficacy.
• Duration of Therapy
o Length of time a medication should be taken to effectively treat a
condition. It is important to follow prescribed durations to ensure that the
medication works as intended and to prevent issues such as drug
resistance or relapse of the condition
• Role of Formularies
o List of medications that are preferred and covered by a particular health
insurance plan or healthcare system. Designed to guide prescribing
practices by promoting cost-effective treatments while ensuring that
effective and safe medications are available.
• Blood Flow Impact on Absorption
o Medications can affect blood flow in various ways, such as by dilating or
constricting blood vessels, impacting blood pressure, or influencing blood
clotting.
Chapter 4:
• Excretion Process
o Involves the removal of drugs and their metabolites from the body
• Metabolism Process
o Body chemically alters drugs for therapeutic use and forms them into
components that can be more easily excreted
• Distribution Process
o Once in the bloodstream, a drug must be distributed to sites of action
throughout the body via the vascular system
• Passage Across Membranes
• Absorption Process
o Process by which a drug moves from its administration site into the blood
stream
• Rate of Dissolution
• Surface Area and Absorption
• Multiple drugs on metabolic pathways
• Therapeutic Consequences
• Impact of drug selectivity on side effects
, o How specifically a medication targets its intended receptor or enzyme.
Highly selective drugs generally produce fewer side effects because they
interact with fewer non-target receptors or enzymes
• Receptors and Selectivity of Drug Action
o Specific proteins on or within cells that drugs bind to produce their effects.
Selectivity of a drug is determined by how well it binds to its intended
receptor compared to other receptors.
• Noncompetitive Antagonists
o Bind to a receptor at a different site than the agonist (the substance that
normally activates the receptor), altering the receptors shape and
preventing the agonist from producing its effect. They inhibit the receptors
activity even in the presence of the agonist
• Noncompetitive Antagonists Action
o Binding to a receptor and changing its conformation, which blocks or
diminishes the receptors response to agonists. This means that even if the
agonist is present, the receptor will not be activated, leading to a reduction
in the intended physiological response.
• Identifying Adverse Drug Reactions
o ARDS – involves monitoring and recognizing unwanted or harmful effects
that occur in response to a medication. This includes looking for
symptoms or signs that deviate from the expected therapeutic effects,
requiring careful observation and reporting to ensure patient safety
Chapter 5:
• FDA & QT Interval Drugs
o The QT interval is a measure on an ECG that represents the time it takes
for the hearts electrical system to reset after each heartbeat. Some drugs
can prolong the QT interval, potentially leading to serious heart
arrhythmias
o The FDA monitors these drugs closely and provides warnings or
recommendations to minimize the risk of complications.
• Boxed Warnings
o Most serious warnings required by the FDA. Highlighted on the drugs label
to alert HCP and patients to the significant risks of severe or life-
threatening adverse effects associated with the medication
• Boxed Warnings: Drug Examples
o Antidepressants: boxed warnings for increased risk of suicidal thoughts in
children, adolescents, and young adults
o Antipsychotics: boxed warnings for increased risk of death in elderly
patients with dementia-related psychosis
o Opioids: boxed warnings for risk of addiction, abuse, and misuse that can
lead to overdose and death
